Radiopharmaceuticals Startup Secures $175M Funding
Aktis Oncology, a radiopharmaceuticals startup, raises $175M to advance targeted cancer treatments, focusing on specific tissues.
- Latest
- Trending
Aktis Oncology, a radiopharmaceuticals startup, raises $175M to advance targeted cancer treatments, focusing on specific tissues.
Ethereum's scaling is unstoppable with Layer 2 solutions enhancing efficiency amid market volatility. Here's a breakdown.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.